Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Published online before print January 19, 2006, 10.1148/radiol.2383041769
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2383041769v1
238/3/827    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schaefer, P. J.
Right arrow Articles by Jahnke, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schaefer, P. J.
Right arrow Articles by Jahnke, T.
(Radiology 2006;238:827-840.)
© RSNA, 2006

Contrast Media

Abdominal and Iliac Arterial Stenoses: Comparative Double-blinded Randomized Study of Diagnostic Accuracy of 3D MR Angiography with Gadodiamide or Gadopentetate Dimeglumine1

Philipp J. Schaefer, MD, Frank P. Boudghene, MD, Hans J. Brambs, MD, Montserrat Bret-Zurita, MD, Jose L. Caniego, MD, Richard A. Coulden, MD, Hans B. Gehl, MD, Renate Hammerstingl, MD, Armin Huber, MD, Ramiro J. Mendez, MD, Michel Nonent, MD, Joerg W. Oestmann, MD, Jesus C. Pueyo, MD, PhD, Siegfried Thurnher, MD, Dominik Weishaupt, MD and Thomas Jahnke, MD

1 From the Department of Diagnostic Radiology, University Hospital of Schleswig-Holstein Campus Kiel, Arnold-Heller-Strasse 9, 24105 Kiel, Germany (P.J.S.). A complete list of centers that participated in this study and author affiliations appears in the Acknowledgment at the end of this article. Received October 14, 2004; revision requested December 22; revision received January 27, 2005; accepted February 28; final version accepted May 11. Supported by a grant from Amersham Health. Address correspondence to P.J.S. (e-mail: jp.schaefer{at}rad.uni-kiel.de).

Purpose: To prospectively evaluate accuracy of gadolinium-enhanced three-dimensional (3D) magnetic resonance (MR) angiography with gadodiamide and gadopentetate dimeglumine (0.1 mmol/kg), with intraarterial DSA as reference standard, for imaging abdominal and iliac arterial stenoses.

Materials and Methods: The study was approved by all institutional review boards; informed consent was obtained from each subject before procedures. Two hundred forty-seven subjects were included; 240 received either contrast agent and were available for safety analysis; 222 were available for accuracy analysis. Enhanced 3D MR angiography and DSA were performed; image data were evaluated in a double-blinded randomized study. Stenoses were classified as not relevant (<50% stenosis) or relevant (≥50%). For detection of main stenosis, accuracy with enhanced 3D MR angiography compared with that with DSA was determined.

Results: The difference in accuracy for imaging with gadodiamide and gadopentetate was 3.6%. Noninferiority was inferred because the lower bound of the exact two-sided 95% confidence interval was –10.1 and was above the noninferiority margin (–15%). Accuracy for detection of the main stenosis was low, 56.4% for gadodiamide and 52.8% for gadopentetate group. Subgroup analysis with exclusion of inferior mesenteric artery and internal iliac arteries and the most false-positive stenosis classifications yielded better results: 76.6% and 71.6%, respectively. Sensitivity, specificity, and negative and positive predictive values did not differ substantially between study groups. In the main analysis, values were 44%, 96%, 35%, and 97% for gadodiamide and 44%, 83%, 30%, and 90% for gadopentetate, respectively. In the subgroup analysis, values were 66%, 95%, 61%, and 96% for gadodiamide and 63%, 86%, 58%, and 88% for gadopentetate, respectively.

Conclusion: Noninferiority of gadodiamide versus gadopentetate was verified based on the primary end point, which was accuracy for detection of the main stenosis with enhanced 3D MR angiography compared with DSA.

© RSNA, 2006




This article has been cited by other articles:


Home page
 RadiologyHome page
G. Soulez, M. Pasowicz, G. Benea, L. Grazioli, J. P. Niedmann, M. Konopka, P. C. Douek, G. Morana, F. K. W. Schaefer, A. Vanzulli, et al.
Renal Artery Stenosis Evaluation: Diagnostic Performance of Gadobenate Dimeglumine-enhanced MR Angiography--Comparison with DSA
Radiology, April 1, 2008; 247(1): 273 - 285.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
S. Thurnher, S. Miller, G. Schneider, C. Ballarati, G. Bongartz, C. U. Herborn, S. Schoenberg, M. A. Cova, G. Morana, K. Niazi, et al.
Diagnostic Performance of Gadobenate Dimeglumine Enhanced MR Angiography of the Iliofemoral and Calf Arteries: A Large-Scale Multicenter Trial
Am. J. Roentgenol., November 1, 2007; 189(5): 1223 - 1237.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
R. Sutter, D. Nanz, A. M. Lutz, T. Pfammatter, B. Seifert, A. Struwe, C. Heilmaier, D. Weishaupt, B. Marincek, and J. K. Willmann
Assessment of Aortoiliac and Renal Arteries: MR Angiography with Parallel Acquisition versus Conventional MR Angiography and Digital Subtraction Angiography
Radiology, October 1, 2007; 245(1): 276 - 284.
[Abstract] [Full Text] [PDF]